Suppr超能文献

CD24亚型a促进细胞增殖、迁移和侵袭,且在肝细胞癌中被早期生长反应因子1(EGR1)下调。

CD24 isoform a promotes cell proliferation, migration and invasion and is downregulated by EGR1 in hepatocellular carcinoma.

作者信息

Li Liangyu, Chen Jing, Ge Chao, Zhao Fangyu, Chen Taoyang, Tian Hua, Li Jinjun, Li Hong

机构信息

Key Laboratory of Medical Molecular Virology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China,

出版信息

Onco Targets Ther. 2019 Feb 28;12:1705-1716. doi: 10.2147/OTT.S196506. eCollection 2019.

Abstract

INTRODUCTION

CD24 is known as a heavily glycosylated cell surface molecule that is highly expressed in a wide variety of human malignancies. Previous studies have shown that CD24 plays an important role in self-renewal, proliferation, migration, invasion and drug resistance of hepatocellular carcinoma (HCC). However, little is known about the expression and function of CD24 isoform a (CD24A) and CD24 isoform b (CD24B) in HCC.

MATERIALS AND METHODS

Quantitative real-time polymerase chain reaction (qPCR) and Western blotting were performed to detect CD24 and EGR1 expression in HCC cells and tissue. The function of CD24 in cell proliferation was verified with MTT assays, colony formation assays and tumor xenograft models. Wound healing assays and invasion assays were performed to clarify the function of CD24 in the regulation of cell migration and invasion in HCC. A dual luciferase reporter assay and chromatin immunoprecipitation assay were used to analyze the regulation mechanism of CD24A.

RESULTS

CD24A but not CD24B, which was barely detected by qPCR and Western blotting, is significantly upregulated in HCC tissue. Both CD24A and CD24B contribute to HCC cell proliferation, migration and invasion, but CD24A is more effective than CD24B. EGR1 downregulates CD24A and exerts transcription-promoting activity on the promoter. Furthermore, EGR1 represses HCC cell proliferation via downregulation of CD24A.

CONCLUSION

CD24A is the predominant CD24 isoform in HCC and plays a major role in cell proliferation, migration, and invasion. EGR1 can exert its antitumor effect through transcriptional downregulation of CD24A in HCC.

摘要

引言

CD24是一种高度糖基化的细胞表面分子,在多种人类恶性肿瘤中高表达。先前的研究表明,CD24在肝细胞癌(HCC)的自我更新、增殖、迁移、侵袭和耐药性中起重要作用。然而,关于CD24异构体a(CD24A)和CD24异构体b(CD24B)在HCC中的表达和功能知之甚少。

材料与方法

采用定量实时聚合酶链反应(qPCR)和蛋白质免疫印迹法检测HCC细胞和组织中CD24和早期生长反应蛋白1(EGR1)的表达。通过MTT法、集落形成试验和肿瘤异种移植模型验证CD24在细胞增殖中的功能。进行伤口愈合试验和侵袭试验以阐明CD24在HCC细胞迁移和侵袭调节中的功能。采用双荧光素酶报告基因试验和染色质免疫沉淀试验分析CD24A的调控机制。

结果

qPCR和蛋白质免疫印迹法几乎未检测到CD24B,而CD24A在HCC组织中显著上调。CD24A和CD24B均促进HCC细胞增殖、迁移和侵袭,但CD24A比CD24B更有效。EGR1下调CD24A并对其启动子发挥转录促进活性。此外,EGR1通过下调CD24A抑制HCC细胞增殖。

结论

CD24A是HCC中主要的CD24异构体,在细胞增殖、迁移和侵袭中起主要作用。EGR1可通过转录下调HCC中的CD24A发挥其抗肿瘤作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e15d/6400134/89af665b7520/ott-12-1705Fig1.jpg

相似文献

1
CD24 isoform a promotes cell proliferation, migration and invasion and is downregulated by EGR1 in hepatocellular carcinoma.
Onco Targets Ther. 2019 Feb 28;12:1705-1716. doi: 10.2147/OTT.S196506. eCollection 2019.
3
Circular RNA circ_0091579 Promotes Hepatocellular Carcinoma Proliferation, Migration, Invasion, and Glycolysis Through miR-490-5p/CASC3 Axis.
Cancer Biother Radiopharm. 2021 Dec;36(10):863-878. doi: 10.1089/cbr.2019.3472. Epub 2020 Jul 14.
4
Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Dig Dis Sci. 2021 Sep;66(9):3074-3085. doi: 10.1007/s10620-020-06641-4. Epub 2020 Oct 11.
5
MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
Ann Hepatol. 2021 Jul-Aug;23:100345. doi: 10.1016/j.aohep.2021.100345. Epub 2021 Mar 31.
8
Downregulation of miR-1225-5p is pivotal for proliferation, invasion, and migration of HCC cells through NFκB regulation.
J Clin Lab Anal. 2020 Nov;34(11):e23474. doi: 10.1002/jcla.23474. Epub 2020 Jul 28.

引用本文的文献

2
TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma.
Cell Oncol (Dordr). 2024 Dec;47(6):2247-2264. doi: 10.1007/s13402-024-01014-9. Epub 2024 Nov 21.
4
EGR1 suppresses HCC growth and aerobic glycolysis by transcriptionally downregulating PFKL.
J Exp Clin Cancer Res. 2024 Jan 29;43(1):35. doi: 10.1186/s13046-024-02957-5.
6
Expression of CD24 as Cancer Stem Cell Marker in the Diagnosis of Oral Squamous Cell Carcinoma - A Prospective Study.
Ann Maxillofac Surg. 2023 Jan-Jun;13(1):26-30. doi: 10.4103/ams.ams_227_22. Epub 2023 Jul 26.
7
Nano-LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec-10 Signaling Pathway.
Adv Sci (Weinh). 2023 May;10(13):e2300288. doi: 10.1002/advs.202300288. Epub 2023 Mar 3.
9
Neutralization of Hv1/HVCN1 With Antibody Enhances Microglia/Macrophages Myelin Clearance by Promoting Their Migration in the Brain.
Front Cell Neurosci. 2021 Oct 22;15:768059. doi: 10.3389/fncel.2021.768059. eCollection 2021.
10
Antibody-drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance.
Clin Transl Oncol. 2022 Mar;24(3):407-431. doi: 10.1007/s12094-021-02707-5. Epub 2021 Sep 30.

本文引用的文献

2
Overview of CD24 as a new molecular marker in ovarian cancer.
J Cell Physiol. 2019 Mar;234(3):2134-2142. doi: 10.1002/jcp.27581. Epub 2018 Oct 14.
3
4
iNOS promotes CD24CD133 liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway.
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10127-E10136. doi: 10.1073/pnas.1722100115. Epub 2018 Oct 8.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.
Cancer Res. 2018 Oct 15;78(20):5877-5890. doi: 10.1158/0008-5472.CAN-18-1011. Epub 2018 Sep 5.
7
Molecular therapies and precision medicine for hepatocellular carcinoma.
Nat Rev Clin Oncol. 2018 Oct;15(10):599-616. doi: 10.1038/s41571-018-0073-4.
8
CD24 regulates sorafenib resistance via activating autophagy in hepatocellular carcinoma.
Cell Death Dis. 2018 May 29;9(6):646. doi: 10.1038/s41419-018-0681-z.
9
CD24 Overexpression Related to Lymph Node Invasion and Poor Prognosis of Colorectal Cancer.
Clin Lab. 2018 Apr 1;64(4):497-505. doi: 10.7754/Clin.Lab.2017.171012.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验